dekenor 25 mg filmtabletta
krka d.d., - dexketoprofen -
algoflex rapid 400 mg lágy kapszula
opella healthcare commercial kft. - ibuprofen -
algoflex rapid mini 200 mg lágy kapszula
opella healthcare commercial kft. - ibuprofen -
okitask 25 mg filmtabletta
dompé farmaceutici s.p.a. - ketoprofen -
okitask 25 mg granulátum
dompé farmaceutici s.p.a. - ketoprofen -
okitask 25 mg pezsgőtabletta
dompé farmaceutici s.p.a. - ketoprofen -
brufen 200 mg filmtabletta
viatris healthcare ltd. - ibuprofen -
brufen 400 mg filmtabletta
viatris healthcare ltd. - ibuprofen -
imfinzi
astrazeneca ab - durvalumab - karcinóma, nem kissejtes tüdő - daganatellenes szerek - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
aspirin ultra 500 mg bevont tabletta
bayer hungária kft. - acetilszalicilsav -